Canada markets open in 17 minutes

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.7200-0.1800 (-4.62%)
At close: 04:00PM EDT
3.8200 +0.10 (+2.69%)
Pre-Market: 08:43AM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-215,058
-225,250
-200,191
-207,279
-146,227
Depreciation & amortization
22,022
22,231
20,920
13,953
8,472
Stock based compensation
62,535
62,908
55,477
43,251
24,761
Change in working capital
-32,014
-46,183
-71,546
-56,816
-40,799
Accounts receivable
-11,105
2,032
-22,648
-7,362
2,613
Inventory
4,880
-2,838
817
-5,200
-4,994
Other working capital
-144,809
-167,021
-200,294
-254,473
-168,486
Other non-cash items
11,302
12,392
8,193
6,950
3,337
Net cash provided by operating activites
-135,525
-156,324
-183,945
-192,727
-149,683
Cash flows from investing activities
Investments in property, plant and equipment
-9,284
-10,697
-16,349
-61,746
-18,803
Purchases of investments
-393,941
-429,558
-278,778
-316,544
-694,965
Sales/Maturities of investments
514,402
569,902
298,032
559,500
596,724
Net cash used for investing activites
111,177
129,647
2,905
181,210
-117,044
Cash flows from financing activities
Common stock issued
-
-
0
0
272,160
Other financing activites
-
-
124,375
429
-321
Net cash used privided by (used for) financing activities
1,617
2,245
132,265
27,146
293,587
Net change in cash
-22,731
-24,432
-48,775
15,629
26,860
Cash at beginning of period
96,927
92,428
141,203
125,574
98,714
Cash at end of period
74,196
67,996
92,428
141,203
125,574
Free Cash Flow
Operating Cash Flow
-135,525
-156,324
-183,945
-192,727
-149,683
Capital Expenditure
-9,284
-10,697
-16,349
-61,746
-18,803
Free Cash Flow
-144,809
-167,021
-200,294
-254,473
-168,486